MSGR
Direxion mRNA ETF
MSGR
MSGR
Delisted
MSGR was delisted on the 21st of April, 2023.
3 hedge funds and large institutions have $1.03M invested in Direxion mRNA ETF in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$10.2K |
Top Sellers
| 1 |
Citigroup
New York
|
-$14.9K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $363K | +$10.2K | +753 | +3% |
|
2
Bank of America
Charlotte,
North Carolina
| $339K | – | – | – |
|
|
3
Citigroup
New York
| $324K | -$14.9K | -1,100 | -4% |
|